PROCEPT BioRobotics Corp (PRCT)
- Analysts10
- Implied upside+75.6%
- Target range$20.00 to $37.00
SEC filings
| Form | Filed | Description |
|---|---|---|
| 4 | June 10, 2026 | FORM 4 |
| 4 | June 10, 2026 | FORM 4 |
| 4 | June 10, 2026 | FORM 4 |
| 4 | June 10, 2026 | FORM 4 |
| 4 | June 10, 2026 | FORM 4 |
| 4 | June 10, 2026 | FORM 4 |
| 4 | June 10, 2026 | FORM 4 |
| 4 | June 10, 2026 | FORM 4 |
Our PRCT coverage
All seven Magnificent Seven stocks fell today. Here's where that money actually went (July 23, 2026)
All seven Magnificent Seven stocks were red by late morning Thursday, led by Tesla's 14% drop on an earnings miss and Alphabet's close-to-7% slide despite beating estimates, on another capex raise. Amazon and Meta sold off too ahead of next week's reports. The money didn't just leave, it rotated: into defense on Lockheed's earnings beat, and out of quantum, SaaS and space.
The Close, July 14: IBM lost a quarter of its value, and SK Hynix's Nasdaq stock jumped 27%
IBM lost about a quarter of its value in a single session after a weak preliminary report, and the damage spread across enterprise software. SK Hynix's brand-new Nasdaq stock went the other way, jumping 27% on a day chips broadly rallied.
Frequently asked questions
What do analysts expect for PRCT?
10 analysts cover PROCEPT BioRobotics Corp (PRCT). The consensus rating is Buy and the average price target is $29.30, in a range of $20.00 to $37.00.
Are insiders buying or selling PRCT?
We have no qualifying Form 4 insider purchases or sales on record for PROCEPT BioRobotics Corp (PRCT). Sales are only tracked above a dollar threshold, so small routine trades may not appear.
Where can I see PRCT SEC filings?
Recent filings are listed on this page, newest first. The latest is a 4 filed June 10, 2026.